Ucb SA UCBJF:OTCPK

RT Quote | Exchange | USD
Last | 04/09/21 EDT
98.00UNCH (UNCH)
52 week range
86.35 - 131.00

...

Loading . . .
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close98.00
  • 52 Week High131.00
  • 52 Week High Date07/31/20
  • 52 Week Low86.35
  • 52 Week Low Date04/22/20

Key Stats

  • Market Cap18,639.62M
  • Shares Out189.03M
  • 10 Day Average Volume990
  • Dividend1.54
  • Dividend Yield1.57%
  • Beta
  • YTD % Change-

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close98.00
  • 52 Week High131.00
  • 52 Week High Date07/31/20
  • 52 Week Low86.35
  • 52 Week Low Date04/22/20
  • Market Cap18,639.62M
  • Shares Out189.03M
  • 10 Day Average Volume990
  • Dividend1.54
  • Dividend Yield1.57%
  • Beta
  • YTD % Change-

RATIOS/PROFITABILITY

  • EPS (TTM)4.73
  • P/E (TTM)20.72
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-
  • ROE (MRQ)-
  • Revenue (MRQ)-
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date05/04/2020
  • Div Amount1.24
  • Split Date-
  • Split Factor-

Latest From Ucb SA

There is no recent news for this security.

Latest From Our Partners

There is no recent news for this security.

Profile

MORE
Ucb SA is a Belgium-based biopharmaceutical and specialty chemical company that specializes in two therapeutic areas: diseases of the central nervous system (CNS) and immunology. In the area of central nervous system disorders, the Company is focused on epilepsy, diabetic neuropathic pain, multiple sclerosis, fibromyalgia, restless legs syndrome and Parkinson’s disease, and the area of immunology includes, bone loss disorders, Crohn’s disease, rheumatoid arthritis and...
Evelyn Diego du Monceau de Bergendal
Non-Executive Chairman
Sandrine Dufour
Chief Financial Officer
Charl Van Zyl
Executive Vice President
Emmanuel Caeymaex
Executive Vice President
Iris Loew-friedrich
Executive Vice President
Antje Witte
Vice President
Address
Allee de la Recherche, 60
Anderlecht
1070
Belgium